Suppr超能文献

急性腹泻的免疫功能正常成年患者中隐孢子虫病的患病率、临床表现及治疗结果

Prevalence, clinical presentation and treatment outcome of cryptosporidiosis in immunocompetent adult patients presenting with acute diarrhoea.

作者信息

Ali Sajjad, Mumar Sunil, Kalam Kiran, Raja Kapeel, Baqi Shehla

出版信息

J Pak Med Assoc. 2014 Jun;64(6):613-8.

Abstract

OBJECTIVE

To document the prevalence, clinical presentation and treatment outcome of cryptosporidiosis in immunocompetent adult patients presenting with acute diarrhoea.

METHODS

This prospective cohort study was conducted at the Sindh Institute of Urology and Transplantation Karachi from February 1, till September 30, 2012. All immunocompetent adult patients who presented with acute diarrhoea to the gastroenterology clinic at SIUT were included. Data collection sheet was filled and stool studies sent. Modified acid fast stain of stool was performed for cryptosporidium. SPSS 20 was used for statistical analysis.

RESULTS

There were 105 patients with acute diarrhoea. Fifty three (50.4%) were males. The mean age was 34 +/- 8.4 years. Of 105, 58 (55%) patients had cryptosporidium isolated in stool studies. Patients with cryptosporidiosis had statistically significant greater stool frequency per day (p < 0.001, OR = 12.7; CI [4.4-37.11), abdominal pain (p < 0.001, OR = 19.8 [6.1-64.11), vomiting (p < 0.001, OR = 7.3 [2.7-19.9]), low grade fever (p < 0.001, OR = 8.5 [3.5-20.8]), fatigue (p < 0.001, OR = 8.4 [3.2-21.6]) and dehydration and a shorter duration of illness with more watery diarrhoea. All 58 patients reported resolution of diarrhoea after 7 days of treatment with nitazoxanide. However, 40 (70.1%) patients reported recurrence of diarrhoea within 6 weeks of treatment.

CONCLUSION

Our study demonstrates a high prevalence of cryptosporidiosis in immunocompetent adult patients. Nitazoxanide is the recommended antimicrobial drug for cryptosporidiosis.

摘要

目的

记录免疫功能正常的成年急性腹泻患者隐孢子虫病的患病率、临床表现及治疗结果。

方法

这项前瞻性队列研究于2012年2月1日至9月30日在卡拉奇的信德泌尿与移植研究所进行。纳入所有因急性腹泻到该研究所胃肠病科就诊的免疫功能正常的成年患者。填写数据收集表并送检粪便样本。对粪便进行改良抗酸染色以检测隐孢子虫。使用SPSS 20进行统计分析。

结果

共有105例急性腹泻患者。其中53例(50.4%)为男性。平均年龄为34±8.4岁。在105例患者中,58例(55%)粪便检测分离出隐孢子虫。隐孢子虫病患者每天的排便次数在统计学上显著更多(p<0.001,OR=12.7;CI[4.4 - 37.11]),有腹痛(p<0.001,OR=19.8[6.1 - 64.11])、呕吐(p<0.001,OR=7.3[2.7 - 19.9])、低热(p<0.001,OR=8.5[3.5 - 20.8])、疲劳(p<0.001,OR=8.4[3.2 - 21.6])以及脱水情况,且病程较短,腹泻更稀。所有58例患者在接受硝唑尼特治疗7天后腹泻症状均缓解。然而,40例(70.1%)患者在治疗后6周内腹泻复发。

结论

我们的研究表明免疫功能正常的成年患者中隐孢子虫病患病率较高。硝唑尼特是推荐用于治疗隐孢子虫病的抗菌药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验